Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular differentiation and proliferation represent two fundamental biological processes rather than a single therapeutic target. Cell proliferation is the increase in cell number through cellular growth and cell division, while cell differentiation is the process by which stem cells or less specialized cells acquire specialized functions and morphology[1][4]. These processes show a remarkable inverse relationship - precursor cells typically continue dividing before acquiring a fully differentiated state, and terminal differentiation usually coincides with proliferation arrest and permanent cell cycle exit[10]. These processes are regulated by complex signaling pathways including MAPK/ERK, PI3K-Akt, JAK-STAT, and others, which control gene expression through transcription factors and chromatin remodeling[3][4][7]. The coordination involves mutual antagonism between cyclin-dependent kinases (CDKs) that promote cell cycle entry and transcription factors that induce tissue-specific gene expression[10]. This should be reclassified as a biological process category rather than treated as a specific therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular differentiation and proliferation.